全文获取类型
收费全文 | 153552篇 |
免费 | 11329篇 |
国内免费 | 7126篇 |
专业分类
耳鼻咽喉 | 905篇 |
儿科学 | 4310篇 |
妇产科学 | 3167篇 |
基础医学 | 22054篇 |
口腔科学 | 3912篇 |
临床医学 | 12085篇 |
内科学 | 23552篇 |
皮肤病学 | 2023篇 |
神经病学 | 11950篇 |
特种医学 | 2690篇 |
外国民族医学 | 51篇 |
外科学 | 11239篇 |
综合类 | 25789篇 |
现状与发展 | 36篇 |
预防医学 | 8311篇 |
眼科学 | 3435篇 |
药学 | 18752篇 |
30篇 | |
中国医学 | 5622篇 |
肿瘤学 | 12094篇 |
出版年
2024年 | 240篇 |
2023年 | 1550篇 |
2022年 | 3425篇 |
2021年 | 5148篇 |
2020年 | 4455篇 |
2019年 | 3796篇 |
2018年 | 3731篇 |
2017年 | 4632篇 |
2016年 | 5164篇 |
2015年 | 5512篇 |
2014年 | 9643篇 |
2013年 | 12008篇 |
2012年 | 10453篇 |
2011年 | 11343篇 |
2010年 | 9165篇 |
2009年 | 8809篇 |
2008年 | 8857篇 |
2007年 | 8488篇 |
2006年 | 7556篇 |
2005年 | 7023篇 |
2004年 | 5787篇 |
2003年 | 4880篇 |
2002年 | 3842篇 |
2001年 | 3335篇 |
2000年 | 2843篇 |
1999年 | 2379篇 |
1998年 | 2142篇 |
1997年 | 1881篇 |
1996年 | 1670篇 |
1995年 | 1346篇 |
1994年 | 1258篇 |
1993年 | 1075篇 |
1992年 | 939篇 |
1991年 | 838篇 |
1990年 | 740篇 |
1989年 | 594篇 |
1988年 | 493篇 |
1987年 | 470篇 |
1986年 | 438篇 |
1985年 | 684篇 |
1984年 | 628篇 |
1983年 | 432篇 |
1982年 | 523篇 |
1981年 | 381篇 |
1980年 | 327篇 |
1979年 | 222篇 |
1978年 | 184篇 |
1977年 | 164篇 |
1976年 | 147篇 |
1975年 | 109篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
41.
《Vaccine》2019,37(24):3234-3240
Leucine aminopeptidase (FhLAP) and cathepsin L1 (FhCL1) of Fasciola hepatica play a critical role in parasite feeding, migration through host tissue, and immune evasion. These antigens have been tested for immune protection as single components with variable degrees of success. The chimeric-protein approach could improve protection levels against fasciolosis. Previously, we reported the design and construction of a chimeric protein composed of antigenic sequences of FhLAP and FhCL1 of F. hepatica. The goal of the present study was to express and evaluate the immune-protective capacity of this chimeric protein (rFhLAP-CL1) in sheep. Animals were randomly allocated into five groups with five animals in each group. Groups 1, 2 and 3 were immunized twice with 100 μg, 200 μg and 400 μg of rFhLAP-CL1 emulsified with Quil A adjuvant, whereas groups 4 and 5 were the adjuvant control and infection control groups, respectively. The animals were then challenged with 200 metacercariae two weeks after the rFhLAP-CL1 booster. The fluke burden was reduced by 25.5%, 30.7% (p < 0.05) and 46.5% (p < 0.01) in sheep immunized with 100 μg, 200 μg and 400 μg of chimeric protein, respectively, in comparison to the infection control group. There was a reduction of 22.7% (p < 0.05) and 24.4% (p < 0.01) in fecal egg count in groups 2 and 3, respectively, compared to the infection control group. Sheep immunized with chimeric protein produced F. hepatica excretion-secretion product-specific total IgG antibody, which were increased after challenge. Moreover, the levels of rFhLAP-CL1-specific IgG1 and IgG2 isotypes in immunized sheep increased rapidly two weeks after the first immunization and were significantly more elevated than those of the control groups, indicating a mixed Th1/Th2 response. This is a preliminary evaluation of the chimeric protein rFhLAP-CL1 as a possible immunogen against F. hepatica infection in sheep. 相似文献
42.
This study aimed to observe the therapeutic effects of magnesium lithospermate B on acute and chronic colitis induced by dextran sodiumsulfate (DSS) and the role of inflammasome complex (NOD-like receptor protein, NLRP; apoptosis-associated speck-like protein containing, ASC; caspase-1). Establishment of acute and chronic colitis models were by using 5% DSS oral administration in BALB/C male mice. Magnesium lithospermate B (240 mg/kg body weight) was given by subcutaneous injection. Samples were collected for biomarker assay, histological examination, immunohistochemical evaluation and western blot. There was obvious increase in TNF-α level and NLPR3, ASC, and caspase-1 expressions in acute and chronic colitis groups compared with the normal control. Significant decrease of the tumor necrosis factor-α level and the expressions of NLPR3, ASC, and caspase-1 were observed after treatment with magnesium lithospermate B. This study showed that magnesium lithospermate B could be used to treat acute and chronic colitis by inhibiting the activation of the NLRP3/ASC/Caspase-1 pathway. 相似文献
43.
目的 探讨γ干扰素诱导蛋白30(IFI 30)、程序性死亡因子配体1(PD-L1)在人脑胶质瘤中的表达及与病人预后的关系。方法 选择2015年5月~2019年5月手术切除的103例人脑胶质瘤组织和瘤旁组织,采用免疫组织化学染色检测IFI 30、PD-L1表达情况。随访24个月,记录无进展生存期和总生存期。结果 胶质瘤组织IFI 30、PD-L1高表达率[分别为70.87%(73/103)、68.93%(71/103)]明显高于瘤旁组织[分别为19.42%(20/103)、21.36%(22/103);P<0.001]。胶质瘤组织IFI 30表达水平与PD-L1表达水平呈明显正相关(r=0.583,P<0.05)。随访24个月,生存75例,死亡28例;多因素logistic回归分析显示,IFI 30高表达、PD-L1高表达是增加病人死亡风险的独立危险因素(P<0.05)。生存曲线分析显示,IFI 30高表达组2年累积生存率(64.52%)和2年累积无进展生存率(65.56%)均明显低于低表达组(分别为82.25%、89.45%;P<0.05)。PD-L1高表达组2年累积生存率(61.78%)和2年累积无进展生存率(60.14%)均明显低于低表达组(分别为88.52%、79.86%;P<0.05)。结论 人脑胶质瘤组织IFI 30、PD-L1呈高表达,与病人不良预后密切相关。 相似文献
44.
Extensive research has indicated that miRNAs are crucial for the occurrence and progression of cancers. miR-451a, involved in breast cancer (BC), is one of the miRNAs. This study focused on the mechanism by which miR-451a regulates BC. The levels of miR-451a in BC tissues and cell lines were examined using quantitative real-time polymerase chain reaction (qRT-PCR). Kaplan‒Meier analysis showed that this was intimately related to the patient's overall survival rate. Functional experiments revealed the negative effects of miR-451a on the abilities of BC cells to multiply (tested by Cell Counting Kit-8), migrate (tested by wound healing assay), and invade (tested by Transwell assay) and its positive effects on apoptosis (tested by flow cytometry). Western blotting indicated that the expression of tumor-related proteins was affected by miR-451a. Moreover, in vivo experiments suggested that tumor growth was clearly restrained by an miR-451a agonist in a xenograft tumor model. Bioinformatic analysis indicated that miR-451a directly targeted Cyclin D2 (CCND2), as demonstrated by the luciferase reporter assay. An opposite change in the level of CCND2 and miR-451a in BC was indicated by qRT-PCR, western blotting, and immunohistochemistry. Subsequently, functional experiments and western blotting analysis confirmed that CCND2 accelerated BC progression, which was regulated by miR-451a. Cumulatively, research on miR-451a may be valuable for BC treatment. 相似文献
45.
《药学学报(英文版)》2020,10(7):1294-1308
A great challenge in multi-targeting drug discovery is to identify drug-like lead compounds with therapeutic advantages over single target inhibitors and drug combinations. Inspired by our previous efforts in designing antitumor evodiamine derivatives, herein selective histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) dual inhibitors were successfully identified, which showed potent in vitro and in vivo antitumor potency. Particularly, compound 30a was orally active and possessed excellent in vivo antitumor activity in the HCT116 xenograft model (TGI = 75.2%, 150 mg/kg, p.o.) without significant toxicity, which was more potent than HDAC inhibitor vorinostat, TOP inhibitor evodiamine and their combination. Taken together, this study highlights the therapeutic advantages of evodiamine-based HDAC1/TOP2 dual inhibitors and provides valuable leads for the development of novel multi-targeting antitumor agents. 相似文献
46.
Javed A. Shaik Nima Estharabadi Ronda S. Farah Maria K. Hordinsky 《Experimental dermatology》2020,29(10):1004-1011
Platelet α-granules release growth factors (GFs) that promote healing and tissue regeneration. Platelet-rich plasma (PRP) is shown to be beneficial in treating alopecia, and however, clinical response can be inconsistent. Due to several fold enrichment of platelets secreting large quantities of GFs following PRP injections, heterogeneity in amounts of GFs secreted by platelets may contribute to inconsistent clinical responses. Herein, we evaluated factors that could potentially contribute to heterogeneous secretion of GFs by platelets. We measured platelet secretion of transforming growth factor beta1 (TGFβ1), platelet-derived growth factor (PDGF-BB), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF2) in aliquots of de-identified PRP samples from female patients undergoing therapy in the hair disease clinic. Although secretion of GFs by platelets was comparable in PRP samples of patients with non-cicatricial and cicatricial alopecia, a Shapiro-Wilk test for normal distribution indicated significant variability across all patient samples. The amount of GF secreted by platelets was comparable when PRP prepared from two FDA-cleared devices with distinct techniques were compared. We provide evidence of platelets secreting heterogeneous amounts of GFs within each sample as high and low secretion of random factors could be simultaneously detected. These results suggest inherent heterogeneity in secretion of GFs by platelets in patient samples that are not influenced by the device used to prepare PRP. Since some GFs could have antagonistic effects on hair growth, a balance between amounts of growth promoting and inhibiting factors may be crucial in determining clinical response to PRP therapy. 相似文献
47.
48.
目的:总结富亮氨酸胶质瘤失活1蛋白(LGI1)抗体阳性边缘性脑炎的临床和影像特点及诊疗预后。
方法:报道我院1例LGI1抗体阳性相关边缘性脑炎并文献复习。结果:患者女性,60岁,表现为渐进性加重
的记忆力减退、癫痫发作(全身强直阵挛发作,面-臂肌张力障碍发作)、低钠血症和轻度精神行为异常。颅 脑MRI-T2/Flair序列提示双侧颞叶(左侧为甚)内侧、海马异常高信号。脑脊液抗LGI1抗体阳性(++)。经激
素治疗症状有所改善。检索既往报道LGI1抗体阳性边缘性脑炎患者237例,多数呈急性、亚急性起病,最
常见是记忆障碍、癫痫(含面-臂肌张力障碍发作)和低钠血症,头颅MRI(特别是MRI-T2/Flair序列)显示单
侧或者双侧海马区、颞叶异常多见,早期免疫治疗预后良好。结论:LGI1抗体阳性相关边缘性脑炎有其特
有的临床特点,免疫治疗可明显改善患者预后。 相似文献
49.
随着对肿瘤热疗和肿瘤免疫微环境(TIME)的深入研究,近年来热疗对TIME的作用越来越受到学者们的重视。本文就目前国内外研究进展,对热疗与TIME中几类主要免疫细胞和免疫相关细胞因子的影响及作用机制作一综述。全面而透彻的了解热疗对TIME的调控作用,有助于为肿瘤治疗提供新的思路和方法。 相似文献
50.
- Download : Download high-res image (66KB)
- Download : Download full-size image